Role of mast cells in oxidized low-density lipoprotein-induced microvascular dysfunction.
Previous studies demonstrated that human low-density lipoprotein (LDL) oxidized with Cu2+ promotes leukocyte-endothelial cell adhesion, mast cell degranulation, and albumin extravasation in rat mesentery. The objective of this study was to determine whether the mast cell degranulation elicited by oxidized LDL accounts for the accompanying microvascular responses. Leukocyte rolling, adherence, and emigration, fluorescein isothiocyanate-albumin leakage, and mast cell degranulation were monitored in rat mesentery before and during local intra-arterial infusion of either normal LDL (nLDL) or copper-oxidized LDL (CuLDL). Infusion of CuLDL, but not nLDL, elicited significant increases in leukocyte rolling, adherence and emigration, albumin leakage, and mast cell degranulation. Pretreatment with the mast cell-stabilizing agent ketotifen or superfusion of the mesenteric microcirculation with iodoxamide significantly reduced CuLDL-induced mast cell degranulation. The mast cell stabilization was accompanied by attenuated leukocyte-endothelial cell adhesion and albumin leakage responses to CuLDL. The results of this study indicate that 1) CuLDL-induced microvascular dysfunction (albumin leakage) involves the activation of mast cells, and 2) the protective action of mast cell stabilizers may be related to their ability to blunt CuLDL-induced leukocyte-endothelial cell interactions in postcapillary venules.
Liao
L
L
Department of Physiology and Biophysics, Louisiana State University Medical Center, Shreveport 71130, USA.
Granger
D N
DN
D000818:Animals; D002199:Capillary Permeability; D002448:Cell Adhesion; D015550:Cell Degranulation / Q000187:drug effects; D002465:Cell Movement; D005260:Female; D006801:Humans; D007665:Ketotifen / Q000494:pharmacology; D007962:Leukocytes / Q000502:physiology; D008077:Lipoproteins, LDL / Q000494:pharmacology; D008297:Male; D008407:Mast Cells / Q000502:physiology*; D008833:Microcirculation / Q000187:drug effects; D010072:Oxamic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012709:Serum Albumin / Q000493:pharmacokinetics; D013152:Splanchnic Circulation / Q000187:drug effects; D014652:Vascular Diseases / Q000139:chemically induced*
D008077:Lipoproteins, LDL; D012709:Serum Albumin; C099252:oxidized low density lipoprotein; D010072:Oxamic Acid; C021702:lodoxamide ethyl; D007665:Ketotifen